Immunic IMUX
NASDAQ IMUX
$8.12 +0.08 (+1.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Immunic (IMUX) Operating Leases (2019 - 2026)

Updated

Analysis

Immunic (IMUX) Operating Leases (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Immunic 341.81 Mn -50.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 328,000.00
Mar 31, 2026 146,000.00
Dec 31, 2025 107,000.00
Sep 30, 2025 126,000.00
Jun 30, 2025 205,000.00
Mar 31, 2025 210,000.00
Dec 31, 2024 264,000.00
Sep 30, 2024 186,000.00
Jun 30, 2024 241,000.00
Mar 31, 2024 433,000.00
Dec 31, 2023 639,000.00
Sep 30, 2023 789,000.00
Jun 30, 2023 1.21 Mn
Mar 31, 2023 1.35 Mn
Dec 31, 2022 992,000.00
Sep 30, 2022 759,000.00
Jun 30, 2022 407,000.00
Mar 31, 2022 502,000.00
Dec 31, 2021 584,000.00
Sep 30, 2021 701,000.00
API Access

Immunic Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=IMUX&period=max&api_key=YOUR_API_KEY